Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Biomarkers in tumors of the central nervous system - a review

Publikation: Bidrag til tidsskriftReviewForskningpeer review

DOI

  1. Bacteremia and urogenital infection with Actinomyces urogenitalis following prolonged urinary retention

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Two cases of tick-borne transmitted tularemia on Southern Zealand, Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Analysis of proximal bone margins in diabetic foot osteomyelitis by conventional culture, DNA sequencing and microscopy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. L-serine: a neglected amino acid with a potential therapeutic role in diabetes

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  5. Erythrocytes restrict microvesicle-induced production of reactive oxygen species by polymorphonuclear leukocytes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. MYCN amplification drives an aggressive form of spinal ependymoma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Skull base versus non-skull base meningioma surgery in the elderly

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Rare cause of spontaneous haemothorax: mediastinal and distant lymph node metastases from uveal melanoma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Molecular Characterization of the Danish Prion Diseases Cohort With Special Emphasis on Rare and Unique Cases

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Until recently, diagnostics of brain tumors were almost solely based on morphology and immunohistochemical stainings for relatively unspecific lineage markers. Although certain molecular markers have been known for longer than a decade (combined loss of chromosome 1p and 19q in oligodendrogliomas), molecular biomarkers were not included in the WHO scheme until 2016. Now, the classification of diffuse gliomas rests on an integration of morphology and molecular results. Also, for many other central nervous system tumor entities, specific diagnostic, prognostic and predictive biomarkers have been detected and continue to emerge. Previously, we considered brain tumors with similar histology to represent a single disease entity. We now realize that histologically identical tumors might show alterations in different molecular pathways, and often represent separate diseases with different natural history and response to treatment. Hence, knowledge about specific biomarkers is of great importance for individualized treatment and follow-up. In this paper we review the biomarkers that we currently use in the diagnostic work-up of brain tumors.

OriginalsprogEngelsk
TidsskriftAPMIS - Journal of Pathology, Microbiology and Immunology
Vol/bind127
Udgave nummer5
Sider (fra-til)265-287
Antal sider23
ISSN0903-4641
DOI
StatusUdgivet - maj 2019

Bibliografisk note

© 2019 APMIS. Published by John Wiley & Sons Ltd.

ID: 58939612